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Purpose: To evaluate an automated method for the quantification of 
fat in the right ventricular (RV) free wall on multidetector 
computed tomography (CT) images and assess its diagnos-
tic value in arrhythmogenic RV cardiomyopathy (ARVC).
Materials and 
Methods:
This study was approved by the institutional review board, 
and all patients gave informed consent. Thirty-six patients 
with ARVC (mean age 6 standard deviation, 46 years 6 
15; seven women) were compared with 36 age- and sex-
matched subjects with no structural heart disease (control 
group), as well as 36 patients with ischemic cardiomyopathy 
(ischemic group). Patients underwent contrast material–
enhanced electrocardiography-gated cardiac multidetector 
CT. A 2-mm-thick RV free wall layer was automatically seg-
mented and myocardial fat, expressed as percentage of RV 
free wall, was quantified as pixels with attenuation less than 
210 HU. Patient-specific segmentations were registered to 
a template to study fat distribution. Receiver operating 
characteristic (ROC) analysis was performed to assess the 
diagnostic value of fat quantification by using task force 
criteria as a reference.
Results: Fat extent was 16.5% 6 6.1 in ARVC and 4.6% 6 2.7 
in non-ARVC (P , .0001). No significant difference was 
observed between control and ischemic groups (P = .23). 
A fat extent threshold of 8.5% of RV free wall was used 
to diagnose ARVC with 94% sensitivity (95% confidence 
interval [CI]: 82%, 98%) and 92% specificity (95% CI: 
83%, 96%). This diagnostic performance was higher than 
the one for RV volume (mean area under the ROC curve, 
0.96 6 0.02 vs 0.88 6 0.04; P = .009). In patients with 
ARVC, fat correlated to RV volume (R = 0.63, P , .0001), 
RV function (R = 20.67, P = .001), epsilon waves (R = 
0.39, P = .02), inverted T waves in V1–V3 (R = 0.38, P = 
.02), and presence of PKP2 mutations (R = 0.59, P = .02). 
Fat distribution differed between patients with ARVC and 
those without, with posterolateral RV wall being the most 
ARVC-specific area.
Conclusion: Automated quantification of RV myocardial fat on multide-
tector CT images is feasible and performs better than RV 
volume in the diagnosis of ARVC.
q RSNA, 2015
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Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a ma-jor cause of ventricular arrhyth-
mia, congestive heart failure, and sud-
den death (1). The diagnosis of ARVC 
is complex and requires compilation 
of clinical, electrophysiologic, struc-
tural, and mechanical features (2). The 
disease is characterized by fibro-fatty 
replacement of normal myocardial tis-
sue, predominantly in the subepicardial 
layers of the right ventricular (RV) free 
wall (3). Myocardial biopsy is only per-
formed in a limited number of patients, 
and, when performed, it is still limited 
by poor sensitivity (4). Imaging is ex-
tensively used in the diagnostic workup 
of ARVC. To improve the reproducibil-
ity of ARVC diagnosis, recent guidelines 
have introduced quantitative criteria 
to document RV dilation or ejection 
fraction (EF) impairment as measured 
with magnetic resonance (MR) imag-
ing or transthoracic echocardiography 
(TTE) (2). The presence of intramyo-
cardial fat on multidetector computed 
tomographic (CT) and MR images has 
been described for decades (5) but is 
not part of these recommendations be-
cause similar features can also be found 
in normal hearts (6). To our knowl-
edge, however, tissue characterization 
with the use of imaging has only been 
evaluated qualitatively, and a quantita-
tive approach may be more appropriate 
because the amount of intramyocardial 
fat is known to be larger in patients 
with ARVC (7). We hypothesized that 
the amount of fat in the RV free wall 
could be quantified with the use of 
Implication for Patient Care
 n Automated quantification of RV 
fat from multidetector CT images 
can be used as a diagnostic fea-
ture in ARVC, particularly in 
patients with implanted cardiac 
devices when MR imaging may 
be contraindicated.
Advances in Knowledge
 n Automated quantification of right 
ventricular (RV) fat on multide-
tector CT images is feasible and 
accurate for the diagnosis of 
arrhythmogenic RV cardiomyop-
athy (ARVC).
 n In ARVC, the extent of RV fat is 
related to RV function (R = 
20.67, P = .001), conduction (R 
= 0.39, P = .02) and repolariza-
tion (R = 0.38, P = .02) distur-
bances, and PKP2 gene mutation 
(R = 0.59, P = .02).
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CI = confidence interval
ECG = electrocardiography
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TTE = transthoracic echocardiography
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multidetector CT and could be useful as 
a diagnostic feature in ARVC. The aim 
of this study was to evaluate an auto-
mated method for the quantification of 
fat in the RV free wall on multidetector 




This study was approved by our in-
stitutional review board, and all pa-
tients gave written informed consent. 
Between November 2012 and Au-
gust 2013, we prospectively included 
36 consecutive patients referred to 
our center for the initial diagnosis of 
ARVC or for the follow-up of a known 
ARVC (29 men with a mean age 6 
standard deviation of 46 years 6 15; 
seven women with a mean age of 47 
years 6 15). The inclusion criterion 
was a definite ARVC diagnosis based 
on current task force criteria (2). 
Exclusion criteria were contraindica-
tions to iodinated contrast media. A 
second group composed of 36 age- and 
sex-matched subjects was recruited 
(seven women aged 47 years 6 15). 
These patients had been referred for 
multidetector CT for assessment of the 
ascending aorta (14 were suspected of 
having aortic aneurysm, and 22 were 
undergoing follow-up for a known an-
eurysm) and had no history of palpi-
tation, syncope, or ventricular ectopy 
and no history or multidetector CT 
features that indicated the presence 
of structural heart disease. A third 
group composed of 36 patients with 
ischemic cardiomyopathy (four women 
aged 62 years 6 12) was recruited 
(ischemic group, with a diagnosis 
based on coronary angiography and 
electrocardiography [ECG] findings). 
Because the ischemic population dif-
fers from the one with ARVC, ischemic 
and ARVC groups were not matched. 
In the three groups, all patients un-
derwent two-dimensional (2D) TTE 
to document left ventricular (LV) EF 
and RV fractional area change. In the 
ARVC group, all patients had under-
gone signal-averaged ECG and 24-hour 
Holter monitoring to document ARVC 
diagnostic criteria. Additionally, 20 of 
36 patients had undergone MR imag-
ing, and MR images were reviewed to 
assess LV EF, RV EF, and LV delayed 
enhancement. In all groups, LV dys-
function was defined as either LV EF 
of less than 57% on MR images (8) or 
LV EF of less than 55% at 2D TTE (9). 
RV dysfunction was defined as either 
RV EF of less than 49% on MR images 
(10) or RV fractional area change of 
less than 32% at 2D TTE (9). Severe 
RV dysfunction was defined as RV EF 
of less than 35% on MR images, RV 
fractional area change of less than 
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Figure 1
Figure 1: Images demonstrate quantification of intramyocardial fat in the RV free wall in a 36-year-old 
man. A, On short-axis CT images, a 3-cm2 region of interest is drawn in a healthy area of the LV myocar-
dium. B, RV endocardium is then automatically segmented by using region growing, the lower threshold be-
ing set 3 standard deviations above mean healthy myocardial attenuation. C, A 2-mm-thick RV free wall layer 
is automatically segmented by using a dilatation operator. D, A threshold is applied to the histogram of wall 
pixels to segment E, areas exhibiting fat attenuation. F, This results in the segmentation of intramyocardial 
fat over the RV free wall, the extent of fat being expressed as a percentage of the wall. G, Endocardial and fat 
segmentations are used to compute patient-specific three-dimensional models displaying fat distribution. 
18% at 2D TTE, or clinical symptoms 
of RV failure. In patients with ARVC, 
biventricular dysplasia was defined as 
either presence of LV dysfunction or 
evidence of LV fibrosis on delayed con-
trast material–enhanced MR images.
Multidetector CT Acquisition
Cardiac multidetector CT was performed 
by using a contrast-enhanced and retro-
spectively cardiac-gated method with a 
64-section scanner (Somatom Defini-
tion; Siemens, Forchheim, Germany). 
Beta-blockers were used unless contra-
indicated in every patient who had ven-
tricular ectopics or a heart rate higher 
than 70 beats per minute. Images were 
acquired during the first pass of iodin-
ated contrast media (400 mg of iodine 
per milliliter of iomeprol; Bracco, Mi-
lan, Italy). To obtain optimal enhance-
ment of the RV chamber, a biphasic 
bolus method was applied—that is, 60 
mL of contrast media delivered at the 
rate of 5 mL/sec, followed by 80 mL of 
a 50:50 mixture of iodinated contrast 
material and saline at the same rate 
(11). Typical acquisition parameters 
were gantry rotation time of 330 msec, 
temporal resolution of 83 msec, colli-
mation of 64 3 0.6 mm, tube voltage 
100–120 kV, and typical tube current of 
600 mAs with a dose modulation pro-
tocol. Effective radiation dose was 7.2 
mSv 6 4.6, 13.2 mSv 6 7.1, and 9.1 
mSv 6 5.2 in the ARVC, control, and 
ischemic groups, respectively. Images 
were reconstructed (B26f kernel filter) 
at end-diastole in a stack of contiguous 
1-mm-thick short-axis sections encom-
passing the whole RV (typical in-plane 
pixel size, 0.4 3 0.4 mm).
Quantification of RV Fat
Image segmentation and fat quantifica-
tion were performed by using an in-
house method developed as a plug-in 
of the software OsiriX 3.6.1 (OsiriX 
Fondation, Geneva, Switzerland). The 
image-processing strategy is illustrated 
in Figure 1. After manual definition of 
tricuspid and pulmonary planes, the 
RV endocardium was automatically 
segmented by using region growing. 
The lower-attenuation threshold ap-
plied for region growing was set 3 
standard deviations above mean myo-
cardial attenuation, as assessed by 
drawing a 3-cm2 region of interest in 
the interventricular septum at mid-
ventricular level. A 2-mm-thick RV 
free wall layer was then automatically 
derived from RV endocardial segmen-
tation by using a dilatation operator. 
Myocardial hypoattenuation was au-
tomatically segmented in the RV free 
wall by using histogram thresholding, 
the cutoff being defined as pixel at-
tenuation of less than 210 HU. This 
threshold was based on prior valida-
tion versus epicardial voltage data in 
patients with ARVC undergoing elec-
troanatomic mapping with image in-
tegration (12). In some patients with 
implantable cardioverter defibrillators 
(ICDs), additional manual segmen-
tation was required to remove metal 
artifacts located at the RV apex. RV 
4 radiology.rsna.org n Radiology: Volume 000: Number 0—! ! ! 2015
CARDIAC IMAGING: Automated Quantification of Right Ventricular Fat at Cardiac Multidetector CT Cochet et al
end-diastolic volume (EDV) was de-
rived from endocardial segmentation 
and expressed in milliliters per square 
meter of body surface area. The extent 
of fat was expressed as percentage of 
RV free wall. Total processing time per 
data set was 5 minutes 6 1. The repro-
ducibility of fat quantification and the 
effect of patient size and image noise 
level on the quantification are analyzed 
in Appendix E1 (online).
Registration of Fat Distribution on the RV 
Template
In all patients, segmentations were used 
to compute three-dimensional maps 
that displayed the distribution of myo-
cardial fat over the RV endocardium. To 
study the distribution of fat in subpop-
ulations, all patient-specific maps were 
registered to an RV template based on 
multidetector CT acquisition in a pa-
tient with average RV size and shape. 
Registration was performed by using 
landmark-based registration with affine 
anisotropic transformation, as imple-
mented in Visualization Toolkit, or VTK 
(Kitware, New York, NY) (13,14). The 
root mean square error on distance af-
ter registration was 3.3 mm 6 3.2. Reg-
istered data sets were then organized 
according to clinical characteristics to 
compute statistical maps displaying 
the likelihood of fat over the RV wall 
in ARVC and non-ARVC groups. An 
illustration of the registration method 
is provided in the Figure E1 (online). 
To compare fat likelihood between RV 
regions, the template was divided into 
seven segments: apical, mid (anterior, 
lateral, inferior), and basal (anterior, 
lateral, inferior).
Statistical Analysis
The Shapiro-Wilk test of normality 
and D’Agostino tests for skewness and 
kurtosis were used to assess whether 
quantitative data conformed to the nor-
mal distribution. Square root transfor-
mation was applied in cases of nonnor-
mal distribution. Continuous variables 
were expressed as means 6 standard 
deviations. Categorical variables were 
expressed as fractions (percentages). 
Continuous variables were com-
pared by using independent-sample 
parametric (unpaired Student t test) 
or nonparametric (Mann-Whitney 
test) tests, depending on data normal-
ity. Relationships between variables 
were assessed by using Pearson or 
Spearman correlation coefficients (R). 
Repeated measures analysis of vari-
ance and Tukey-Kramer multiple com-
parison tests were used to compare (a) 
the global extent of fat between ARVC, 
ischemic, and control groups; (b) RV 
EDV between ARVC, ischemic, and 
control groups; and (c) the extent of 
fat between segments in each group. 
The extent of fat between segments 
in each group was expressed as a per-
centage of the segment of interest. The 
diagnostic performance of fat and RV 
EDV to diagnose ARVC was assessed 
by using receiver operating charac-
teristic (ROC) curve analysis. Areas 
under ROC curves were compared by 
using Z statistics. All statistical tests 
were two tailed. A P value less than 
.05 was considered to indicate a statis-
tically significant difference. Analyses 
were performed by using NCSS version 
8 (NCSS Statistical Software, Kaysville, 
Utah), except for agreement and cor-
relation ratio analyses (R statistical 




The characteristics of the ARVC popu-
lation are provided in Table E1 (on-
line). All patients had a definite ARVC 
diagnosis based on current task force 
criteria. Time since first diagnosis 
was 25 months (range, 0–87 months). 
Signal-averaged ECG, 24-hour Holter 
monitoring, and 2D TTE had been 
performed in all patients within the 
past month. MR imaging had been per-
formed in 20 patients. The mean time 
since last MR imaging examination 
was 12 months (range, 0–42 months) 
in these patients. Genetic testing for 
PKP2 mutations had been performed 
in 16 patients. None of the patients 
had undergone endomyocardial biopsy. 
The mean numbers of major and mi-
nor criteria at the time of inclusion in 
the current study were 2.0 6 1.3 and 
2.2 6 1.2, respectively.
In the ischemic group (four women 
with a mean age of 62 years 6 12, a 
mean weight of 82 kg 6 12, and a body 
mass index of 28.0 kg/m2 6 4.3), all 
patients had a history of prior myo-
cardial infarction. Multivessel disease 
was present in eight of 36 patients. 
The right coronary artery was in-
volved in 15 patients, the left anterior 
descending artery in 18 patients, the 
circumflex artery in six patients, and 
the left main artery in three patients. 
None of the patients exhibited RV 
dysfunction at TTE. Mean LV EF was 
45% 6 22 at 2D TTE. The indication 
for multidetector CT in the ischemic 
group was the assessment of proximal 
stents in 16 patients, the detection of 
intracardiac thrombus in 11 patients, 
the measurement of aortic aneurysms 
in six patients, and the characteriza-
tion of aortic valve stenoses in three 
patients. In the control group (seven 
women with a mean age of 47 years 
6 15, mean weight of 75 kg 6 13, and 
body mass index of 24.8 kg/m2 6 3.5), 
all patients had been referred for mul-
tidetector CT for assessment of the 
ascending aorta and had no history of 
palpitation or syncope and no history 
or multidetector CT features that indi-
cated the presence of structural heart 
disease. None of the patients exhibited 
RV dysfunction at TTE. Mean LV EF 
was 61% 6 7 at 2D TTE.
Extent of Fat and RV Volume in ARVC and 
Non-ARVC
Multidetector CT measurements of RV 
fat extent and RV EDV values for each 
group are presented in Figure 2. RV 
EDV was 126 mL/m2 6 38, 77 mL/m2 
6 19, and 75 mL/m2 6 17 mL/m2 in 
ARVC, ischemic, and control groups, 
respectively. RV EDV was higher in 
the ARVC group versus the ischemic 
and control groups (P , .0001 for 
both comparisons). No significant dif-
ference in RV EDV was found between 
ischemic and control groups (P = .61). 
Fat extent was 16.5% 6 6.1, 5.0% 6 
2.7, and 4.2% 6 2.6 of RV free wall in 
ARVC, ischemic, and control groups, 
respectively. RV fat extent was higher 
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Figure 3
Figure 3: ROC curve is shown for the diagnosis of 
ARVC. The diagnostic performance of fat extent was 
higher than that for RV EDV (area under the ROC 
curves, 0.96 6 0.02 vs 0.88 6 0.04, respectively; 
P = .009). The optimal cutoff value of 8.5% fat 
was used to diagnose ARVC with 94% sensitivity 
(95% CI: 82%, 98%) and 92% specificity (95% CI: 
83%, 96%). The optimal cutoff value of 106 mL/
m2 RV EDV was used to diagnose ARVC with 72% 
sensitivity (95% CI: 56%, 84%) and 94% specificity 
(95% CI: 87%, 98%).
Figure 2
Figure 2: Box and whisker plots show RV EDV and fat extent values in ARVC, control, and ischemic 
groups. RV EDV was higher in patients with ARVC (n = 36; mean age, 46 years 6 15; seven women) 
versus control subjects (n = 36; mean age, 47 years 6 15; seven women) and ischemic patients (n = 
36; mean age, 62 years 6 12; four women) (P , .0001 for both comparisons) and was not significantly 
different between control subjects and ischemic patients (P = .61). Fat extent in RV free wall was higher 
in patients with ARVC versus control subjects and ischemic patients (P , .0001 for both comparisons) 
and was not significantly different between control subjects and ischemic patients (P = .23). NS = not 
significant.
in the ARVC group versus the ische-
mic and control groups (P , .0001 
for both comparisons). No significant 
difference in RV fat extent was found 
between ischemic and control groups 
(P = .23). ROC analysis is illustrated 
in Figure 3. The optimal cutoff value of 
8.5% fat was used to diagnose ARVC 
with 94% sensitivity (95% confidence 
interval [CI]: 82%, 98%) and 92% 
specificity (95% CI: 83%, 96%). The 
optimal cutoff value of 106 mL/m2 RV 
EDV was used to diagnose ARVC with 
72% sensitivity (95% CI: 56%, 84%) 
and 94% specificity (95% CI: 87%, 
98%). The diagnostic performance of 
fat extent was significantly higher than 
the one of RV EDV (area under the 
ROC curves, 0.96 6 0.02 vs 0.88 6 
0.04, respectively; P = .009). Of note, 
fat extent was lower in patients who 
had a recent diagnosis of ARVC (,12 
months) than in others (14.0% 6 4.9 
of RV free wall versus 18.3% 6 6.4, re-
spectively; P = .04). As a consequence, 
the sensitivity in diagnosing ARVC 
decreased when considering only pa-
tients with a recent ARVC diagnosis 
(sensitivity, 87%). Figure 4 shows ex-
amples of fat quantification in patients 
with and those without ARVC.
Correlates of RV Fat
In patients without ARVC, RV fat ex-
tent was not found to be related to 
age (R = 0.10, P = .39), RV EDV (R = 
0.05, P = .65), RV systolic function at 
TTE (R = 20.04, P = .68), LV systolic 
function at TTE (R = 0.04, P = .69), 
body weight (R = 20.11, P = .35), or 
body mass index (R = 20.09, P = .43). 
The correlates of RV fat in ARVC are 
provided in Table E2 (online). Among 
diagnostic task force criteria, RV fat 
was found to be inversely related to 
RV EF and positively related to RV 
EDV, presence of epsilon wave, in-
verted T waves in V1–V3, and PKP2 
mutations. RV fat extent was 20.0% 
6 5.9 when epsilon wave was present 
and 14.9% 6 5.7 otherwise (P = .02). 
It was 18.2% 6 6.3 when inverted 
T waves in V1–V3 were present and 
13.4% 6 4.5 otherwise (P = .02). It 
was 20.9% 6 4.3 when PKP2 muta-
tions were present and 13.8% 6 6.9 
otherwise (P = .03). When analyzing 
results of multidetector CT–derived 
fat quantification in patients with 
ARVC who had also undergone MR 
imaging (n = 20 patients, with positive 
MR imaging findings in 16), RV fat ex-
tent was above the 8.5% threshold in 
18 of 20 patients, including two with 
negative MR imaging findings. The 
two patients with RV fat extent below 
the 8.5% threshold also had negative 
MR imaging findings.
Distribution of Fat over the RV Free Wall
The distribution of fat over the RV free 
wall in patients with ARVC and those 
without ARVC is illustrated in Figure 5. 
In patients with ARVC, significant differ-
ences were found between RV segments 
(F ratio = 3.13, P = .008). Fat extent was 
higher in basal lateral segments than in 
mid lateral and apical segments (P = .03 
and P = .001, respectively), higher in 
mid anterior segments than in mid lat-
eral and apical segments (P = .01 and 
P = .0002, respectively), and higher in 
basal anterior and basal inferior seg-
ments than in apical segments (P = .04 
and P = .001, respectively). In patients 
without ARVC, significant differences 
were also found between RV segments 
(F ratio = 3.89, P = .001). Fat extent was 
higher in mid anterior segments than 
in basal anterior, basal lateral, basal in-
ferior, and mid inferior segments (P = 
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Figure 4
Figure 4: Examples of fat quantification in patients with and those without ARCV are shown. A–D, A 61-year-old man received a 
diagnosis of ARVC on the basis of task force criteria. A, Multidetector short-axis CT image, B, histogram analysis, C, segmented image, 
and D, patient-specific three-dimensional model in the anteroposterior view are shown. The extent of fat was 12.5% of RV free wall. RV 
EDV was 95 mL/m2. E–H, A 42-year-old man had been referred for cardiac multidetector CT for measurement of the ascending aorta. 
The patient had no history of palpitation, syncope, or ventricular ectopy and no history or multidetector CT features that indicated the 
presence of structural heart disease. E, Multidetector short-axis CT image, F, histogram analysis, G, segmented image, and H, patient-specific 
three-dimensional model in the anteroposterior view are shown. The extent of fat was 3.2% of RV free wall. RV EDV was 71 mL/m2.
.005, P = .01, P = .007, and P = .02, 
respectively). It was also higher in mid 
lateral and apical segments than in basal 
anterior segments (P = .04 and P = .04, 
respectively).
Discussion
An automated method for the quan-
tification of intramyocardial fat in the 
RV free wall from multidetector CT im-
ages appears to be feasible. The per-
formance of RV fat extent for the di-
agnosis of ARVC is superior to that of 
RV volume, yielding similar specificity 
and markedly improved sensitivity. Fat 
burden is related to RV dysfunction as 
well as conduction and repolarization 
disturbances in ARVC.
Diagnosis of ARVC
Evidence of intramyocardial fat at imag-
ing in ARVC was first reported by Wolf 
et al in 1989 (15) with the use of MR 
imaging. Because fat tissue is charac-
terized by low attenuation as compared 
with the myocardium, intramyocardi-
al fat has also been described on CT 
images (16). These features were the 
hallmark of ARVC diagnosis at imag-
ing in the 1990s but were progressively 
abandoned on the basis of subjectivity 
and poor reproducibility of the qualita-
tive analysis (17). Additionally, several 
histologic and imaging reports have 
described fatty infiltration in patients 
without ARVC (5,6). For these reasons, 
the presence of RV fat on images is not 
part of current recommended criteria 
to diagnose ARVC (2). In the present 
study, an automated and quantitative 
method was used for the assessment of 
intramyocardial fat in the RV free wall. 
Although fat can also be assessed at MR 
imaging, we chose to use multidetector 
CT because high blood pool attenuation 
allows for automated endocardial seg-
mentation (18) and because its higher 
spatial resolution is particularly adapt-
ed to the study of the thin RV wall. The 
choice of a 2-mm thickness in which RV 
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Figure 5
Figure 5: A–F, Parametric maps display the distribution of myocardial fat over RV free wall. Fat likelihood 
is shown for patients with ARVC (n = 36; mean age, 46 years 6 15; seven women) and control subjects (n 
= 36; mean age, 47 years 6 15; seven women) in A, D, lateral, B, E, inferior, and C, F, anterior views.
wall densities were analyzed was based 
on previously reported normal values of 
RV wall thickness (19). Indeed, because 
it predominates in subepicardial layers 
of the myocardium, it is often not pos-
sible to discriminate between abnormal 
intramyocardial fat and normal epicar-
dial fat. Thus, any fat attenuation found 
less than 2 mm from the endocardium 
can be considered abnormal and re-
lated to either intramyocardial fat or 
severe wall thinning. We acknowledge 
that when analyzing a 2-mm-thick wall, 
areas of intramyocardial fat located 
more than 2 mm from the endocardium 
are missed. However, the validity of 
the approach was recently established 
in a contact mapping study in patients 
with ARVC who were undergoing ven-
tricular tachycardia ablation, demon-
strating high correlation of multidetec-
tor CT–derived fat segmentation with 
voltage mapping and ablation targets 
(12). The current study demonstrates 
that the method can also be used for 
diagnostic purposes, fat quantification 
being highly reproducible and accurate 
for the diagnosis of ARVC. The high 
reproducibility of both RV EDV and 
fat measurements can be explained by 
the limited number of user interactions 
during the quantification process. The 
only manual tasks are the definition of 
a region of interest in a healthy LV myo-
cardial area to define the lower thresh-
old for subsequent automated blood 
pool segmentation and the definition of 
pulmonary and tricuspid planes. Addi-
tional studies should be performed to 
document the reproducibility between 
different acquisitions in the same pa-
tient. For radiation exposure issues, 
this reproducibility was not explored in 
the current study.
Clinical Correlates of RV Fat
When compared with task force cri-
teria, our results indicate that fat 
quantification performs better than RV 
EDV in the diagnosis of ARVC, yielding 
similar specificity (92% vs 94%) and 
markedly improved sensitivity (94% 
vs 72%). The extent of fat was also 
strongly associated with MR imaging 
results as expected and yielded pos-
itive results in two of four patients 
with ARVC who had negative MR im-
aging findings. RV fat extent was also 
strongly related to the presence of epsi-
lon wave, whereas no relationship was 
found with late potentials at signal-av-
eraged ECG. This might be explained 
by the high sensitivity of signal-aver-
aged ECG in the detection of conduc-
tion abnormalities even in patients 
with limited substrate, whereas the 
presence of epsilon waves at standard 
ECG might require a larger amount of 
substrate. The extent of fat was also 
related to inverted T waves in V1–V3, 
indicating that such repolarization dis-
turbances also require large amounts 
of substrate to be observed at surface 
ECG. Interestingly, the extent of fat 
was found to be higher in patients with 
PKP2 mutations than in those without. 
This suggests that the impairment in 
desmosomal adhesion caused by pla-
kophilin 2 mutations might result in a 
distinctive phenotype of the disease. 
Our results show that the extent of fat 
in the RV free wall is also closely re-
lated to RV function, which indicates 
a potential value for risk stratification 
(20). However, no relationship was 
found between the extent of fat in RV 
free wall and the presence of LV in-
volvement, which is consistent with 
prior reports of LV variants of arrhyth-
mogenic cardiomyopathy with minimal 
RV involvement (21). When analyzing 
arrhythmic events, the extent of fat in 
RV free wall was not found to be re-
lated to sustained ventricular tachycar-
dia as a first symptom, history of syn-
cope, sudden cardiac arrest, ablation, 
or ICD. Because only three patients 
with ICD had not undergone therapy, 
ICD therapy could not be tested. In 
prior studies, intramyocardial RV fat 
was found to be associated with age 
at histologic examination (22), and 
myocardial lipid content as measured 
in the left ventricle with MR imaging 
spectroscopy was also found to be re-
lated to age (23). In the present study, 
however, no significant correlation was 
found between RV fat and age, weight, 
or body mass index. We hypothesized 
that fat induced by age or metabolic 
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disorders is not clustered enough to be 
quantified by using our multidetector 
CT approach, because of partial vol-
ume effect. Indeed, observing a mean 
attenuation below 210 HU in a 0.4-
mm3 pixel would require a macroscopi-
cally clustered fat infiltrate. Therefore, 
our method might be adapted to the 
detection and/or characterization of 
intramyocardial fat associated with fo-
cal diseases (inflammatory, ischemic, 
dysplasic), but possibly not to a diffuse 
increase in lipid content secondary to 
aging or metabolic disorders.
Regional Distribution of Fat over the RV 
Free Wall
Our results show that fatty infiltration in 
ARVC is regionally distributed. Fat pre-
dominates on basal lateral and anterior 
RV outflow tract areas, which is consis-
tent with prior pathologic reports (6). 
In patients without ARVC, the segmen-
tation also shows a regional distribution 
of fat densities, with predominance on 
anterior RV outflow tract. We hypoth-
esize that this is rather due to epicar-
dial fat included in the 2-mm thickness 
of the wall than to intramyocardial fat. 
Indeed, anterior RV outflow tract is 
known to be the area where the RV wall 
is the thinnest (24). This indicates that 
when using automated quantification 
of fat with the proposed method, basal 
lateral fat is more specific for ARVC 
than RV outflow tract fat. Therefore, a 
regional analysis of fat could potentially 
further improve the performance of the 
method for diagnosis or disease char-
acterization. Such a regional approach 
could be of interest to characterize pa-
tients with ARVC with different geno-
types or different clinical presentations 
(arrhythmia vs heart failure) or to as-
sist in differential diagnosis (sarcoido-
sis, RV infarction). These perspectives 
should be addressed in future studies.
Study Limitations
The first limitation of this study is re-
lated to its case-control design and to 
the limited sample size. We only stud-
ied patients with definite ARVC, task 
force criteria being used as a reference 
standard. The value of multidetector 
CT–derived fat quantification in patients 
with borderline and possible ARVC di-
agnosis remains unknown and should 
be assessed prospectively versus patient 
outcome. In addition, the time to first 
diagnosis was variable in the ARVC pop-
ulation, ranging from 0 to 87 months, 
and it fairly but significantly correlated 
with fat extent. This reflects the natural 
disease progression, since initial diagno-
sis but might have introduced a certain 
degree of overestimation in sensitivity. 
Regarding the method, we acknowledge 
that the proposed segmentation does 
not quantify septal and LV substrate 
because it is focused on RV free wall. 
A quantification of fat in the LV wall 
would be feasible by using a similar ap-
proach, but we believe that qualitative 
assessment of myocardial fat is sufficient 
in the left ventricle because it is less 
limited than on the thin RV wall. An-
other potential limitation is the absence 
of functional evaluation at multidetector 
CT. Indeed, it was shown to be feasible 
and particularly useful in patients with 
ICD implants and contraindications to 
MR imaging (25). A combination with 
fat quantification would therefore be 
feasible. However, the radiation dose as-
sociated with multidetector CT can be 
viewed as a limitation, particularly when 
assessing cardiac motion over the whole 
cycle. Last, the reproducibility between 
different acquisitions and different scan-
ners was not specifically analyzed and 
should be addressed in future studies.
In conclusion, automated quantifi-
cation of RV fat from multidetector CT 
images is feasible and could be used to 
assist the diagnosis of ARVC. In ARVC, 
fat burden is related to RV function, 
conduction, and repolarization distur-
bances and PKP2 mutation.
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